Corporate News-Good Doctor

Blog

——

2026.04.20

Good Doctor·Hyperthermic Perfusion | The “Elite Pursuit of Excellence” Furnace Program — Standardized Training on Cavity Hyperthermic Perfusion Therapy, Session 3 of 2026 (Overall Session 7) (Xi’an Headquarters) Concluded Successfully

2026.04.13

Good Doctor·Hyperthermic Perfusion | “Elite Pursuit of Excellence” Foundry Program — The 2026 Standardized Spring Training Camp on Intracavitary Hyperthermic Perfusion Therapy (Shanxi Station) Concluded Successfully

“Empowering clinical practice, fostering shared development.” Recently, the two-day “Elite Pursuit of Excellence” Foundry Program—2026 Standardized Spring Training Camp on Hyperthermic Intracavitary Perfusion Therapy (Shanxi Station)—concluded successfully in Taiyuan.

2026.03.22

Good Doctor·Hyperthermic Perfusion | The First Session of Standardized Clinical Application Training for Hyperthermic Perfusion Therapy Machines in 2026 Concludes Successfully

From March 21 to 22, 2026, the first session of the 2026 Standardized Clinical Application Training on GD Hyperthermic Perfusion Therapy Devices successfully concluded. Medical professionals and partners from across the country gathered to enhance their skills through learning and to drive improvement through exchange, thereby injecting new momentum into the standardized development of hyperthermic perfusion therapy for cancer.

2026.03.20

Good Doctor·Hyperthermic Perfusion | The Hazards of Malignant Ascites and a Core Analysis of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Cancerous ascites, also known as malignant ascites, is a pathological condition in which malignant tumors invade intra-abdominal organs and metastasize to the retroperitoneum, leading to an abnormal increase and accumulation of fluid within the peritoneal cavity. It is a common complication of advanced malignancies, such as gastric cancer, colorectal cancer, ovarian cancer, and pancreatic cancer. Cancerous ascites severely impairs patients’ quality of life, accelerates disease progression, and serves as a significant indicator of poor prognosis in patients with advanced cancer. According to clinical data, approximately 15%–20% of patients with advanced malignancies develop cancerous ascites, with the highest incidence observed in ovarian and gastric cancer—ranging from 50%–70% and 30%–40%, respectively. Among patients with advanced cancer complicated by cancerous ascites, the median survival is typically less than six months.

2026.02.27

Good Doctor: Hot Infusion | United in Purpose, Striving for New Success—Spring Empowerment Training for 2026

The New Year ushers in a new beginning, and now is the time to forge ahead with determination. To further implement the company’s management system, enhance the overall competence and professional skills of all employees, and support the company’s steady development, on February 25, 2026, Good Doctor organized the “Unite as One, Forge Ahead for Mutual Success—2026 Spring Empowerment Training.” All employees gathered together to learn and grow side by side, using learning to fuel personal growth and training to drive practical action. United in purpose, we set out on a new journey of vigorous advancement for the coming year.

2026.02.13

Good Doctor – Thermal Perfusion | United in Solidarity, Embarking on a New Journey

As the year draws to a close and the new year begins, today’s 2025 Chairman’s Work Report and Annual Excellence Awards Ceremony concluded successfully. All company employees gathered together to jointly review the journey and remarkable achievements of 2025, recognize outstanding individuals, unite our strengths, and look forward to writing a new chapter in our future development.

2026.02.11

Good Doctor – Hot Perfusion | The 2025 Mid-Level and Core Staff Year-End Performance Review Conference Concluded Successfully

2026.02.03

Good Doctor – Hyperthermic Perfusion | Controlling Malignant Pleural Effusion, Improving Patients’ Quality of Life and Survival Duration

< 1 2 3 4 5 6 > proceed page

· GDHIPEC from China ,

· Caring for Patients Worldwide ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!